dehydroepiandrosterone sulfate has been researched along with 9,10-dimethyl-1,2-benzanthracene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Labrie, F; Marchetti, B; Spinola, PG | 1 |
| Bélanger, A; Labrie, F; Li, S; Yan, X | 1 |
| Ciolino, HP; Yeh, GC | 1 |
3 other study(ies) available for dehydroepiandrosterone sulfate and 9,10-dimethyl-1,2-benzanthracene
| Article | Year |
|---|---|
Adrenal steroids stimulate growth and progesterone receptor levels in rat uterus and DMBA-induced mammary tumors.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Adrenal Cortex Hormones; Androstenediol; Androstenedione; Animals; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Mammary Neoplasms, Experimental; Ovariectomy; Promegestone; Rats; Rats, Inbred Strains; Receptors, Progesterone; Uterus | 1986 |
Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(a)anthracene (DMBA) in the rat.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Drug Implants; Female; Luteinizing Hormone; Mammary Neoplasms, Experimental; Ovariectomy; Prolactin; Rats; Rats, Sprague-Dawley; Time Factors | 1994 |
The steroid hormone dehydroepiandrosterone inhibits CYP1A1 expression in vitro by a post-transcriptional mechanism.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Carcinogens; Cytochrome P-450 CYP1A1; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dose-Response Relationship, Drug; Humans; Neoplasms; Polychlorinated Dibenzodioxins; Reverse Transcriptase Polymerase Chain Reaction; RNA Processing, Post-Transcriptional; RNA, Messenger; Time Factors; Transfection; Tumor Cells, Cultured | 1999 |